Lexicon Pharmaceuticals reported $-24587000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbott ABT:US $ 2018M 429M
Acadia Pharmaceuticals ACAD:US $ -34.01M 79.04M
Acorda Therapeutics ACOR:US $ -46.68M 22.16M
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
Alnylam Pharmaceuticals ALNY:US $ -277.4M 37.06M
AstraZeneca AZN:LN 29568.96M 177.38M
Biomarin Pharmaceutical BMRN:US $ 27.66M 93.13M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Clovis Oncology CLVS:US $ -71.33M 11.16M
Eli Lilly And LLY:US $ 952.5M 950.4M
Esperion Therapeutics ESPR:US $ -66324000 9.59M
Halozyme Therapeutics HALO:US $ 22.68M 37.42M
Illumina ILMN:US $ -535M 621M
Insmed INSM:US $ -95645000 1.02M
Intercept Pharmaceuticals ICPT:US $ -7.53M 9.76M
Ironwood Pharmaceuticals IRWD:US $ 37.08M 1.72M
Johnson & Johnson JNJ:US $ 4814M 335M
Lexicon Pharmaceuticals LXRX:US $ -24.59M 1.11M
Macrogenics MGNX:US $ -41.3M 25.14M
Mannkind MNKD:US $ -29.02M 3.02M
Merk MRK:US $ 3944M 366M
Moderna Inc MRNA:US 2.2B 1.46B
Novartis NOVN:VX SF 1694M 528M
Ptc Therapeutics PTCT:US $ -152.09M 25.36M
Puma Biotechnology PBYI:US $ 9.37M 12.77M
Regulus Therapeutics RGLS:US $ -7.26M 0.54M
Sarepta Therapeutics SRPT:US $ -231.48M 126.46M
Thermo Fisher Scientific TMO:US $ 1664M 551M
Ultragenyx Pharmaceutical RARE:US $ -158.16M 5.84M
United Therapeutics UTHR:US $ 116M 123.9M